Accessibility: Skip TopNav
Atsena Therapeutics
Lis Leiderman, MD, MBA, Chief Financial Officer and Chief Business Officer
Format
PNG
Quelle:
Atsena Therapeutics
Downloads
Originalgröße
Groß
Mittel
Klein